DriSate Product Code DR-145 The acid concentrate powders and liquids are indicated for…
Recall Z-1869-2018, part of FDA recall event 79878. See Rockwell Medical's company page.
Rockwell Medical, Inc started this Class II device recall on Apr 7, 2018 (voluntary: firm initiated); FDA lists it as terminated, terminated Oct 1, 2018.
- Classification: Class II
- Started: Apr 7, 2018
- Status: Terminated
A subassembly component (dextrose bag) within this case product contained small amounts of sodium bicarbonate from a prior batch.
- Product
- DriSate Product Code DR-145 The acid concentrate powders and liquids are indicated for use in acute and chronic hemodialysis and to be used with the appropriate hemodialysis machine/monitor and bicarbonate concentrate.
- Quantity
- 139
- Lots and codes
- Lot 28562-0220171
- Distribution
- US Distribution to the state of NY
- Recalling firm
- Rockwell Medical, Inc, Wixom, MI, United States
- How the firm notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- FDA classified
- May 14, 2018
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports